Over the past decade, the cardiovascular care of patients with cancer has evolved as a subspecialty driven by novel therapies that can cure or control patients, allowing many patients to be living long enough to experience the potential cardiotoxic effects of these treatments. The purpose of this conference is to provide a case-based curriculum that addresses important clinical topics relevant to the cardiovascular health of patients with cancer. Clinical experts from Memorial Sloan Kettering Cancer Center and around the country will present an up-to-date overview on the best practice strategies in the evaluation and management of heart disease in cancer patients from early diagnosis, treatment and long-term surveillance. All presentations will include devoted time to permit interaction between audience members and presenters. There will be a separate computer-based session on how to perform and analyze global longitudinal strain (details below).

Target audience

This course is intended for cardiologists, internists, hematologists/oncologists and other affiliated healthcare professionals who are involved in the care of cancer patients or have a special interest in this area.

Computer Based Hands-On Learning Lab (Optional)
How to Perform and Analyze Global Longitudinal Strain (GLS) - Tips and Tricks

The aim of the learning lab is to provide participants personalized hands-on experience in GLS performance and analysis. Following an introductory lecture on the clinical application of strain, participants will analyze real cases pre-loaded on their own computer workstation under the supervision of the faculty. Tips on acquiring optimal 2D images for speckle tracking and step-by-step how to perform and analyze 2D GLS will be demonstrated with examples of common pitfalls to avoid.  Seating is limited to allow each participant sufficient opportunity to interact with faculty - please be sure to register early.

1. State best practice strategies in cardiotoxicity monitoring and management for patients receiving breast cancer treatment.
2. Recognize the cardiovascular concerns with conventional and newer targeted therapy used to treat cancer and the timeline of the cardiotoxicity manifestation.
3. Describe emerging cardiotoxicity associated with immunotherapy and management of immunotherapy related myocarditis.
4. State specific examples of cardiovascular challenges during cancer therapy.
5. Describe radiation induced heart disease and recognize the development of practice change in radiotherapy over time
6. Illustrate the utility of preclinical biomarkers for cardiotoxicity monitoring.
7. Define the role of imaging studies in the detection and prediction of cardiotoxicity.
8. Identify late onset cardiotoxicity in adult survivors of childhood cancer.
9. Discuss the implementation of cardio-oncology practice guidelines to formulate best practice strategies.
10. State the goals and principles of a multidisciplinary team in cardio-oncology and the approach to building a cardio-oncologic clinic

*Industry professionals may attend CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.

Registration includes access to an online course syllabus (with downloadable PDF files), continental breakfast, lunch, and refreshment breaks. Please contact cme@mskcc.org at least one week prior to the course if you have any special dietary needs.

• 30% Discounted Rate for MSK Alumni and MSK Alliance Members - MSK offers a discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact cme@mskcc.org for more information or to register.
• MSK Staff Registration - Registration is complimentary for MSK staff. However, you must complete course registration to attend this course. 

Cancellation Policy

If you cancel your participation in this course, your registration fee, less a $75 administrative fee, will be refunded when email notification is received by the MSK Office of Continuing Medical Education (MSK CME) at least 7 days prior to the first day of the course (cme@mskcc.org).

Cancellations or no-shows after this date are not eligible for a refund. MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, we will refund the registration fee in full, but are not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies. At any time, you may substitute another registrant in your place after contacting MSK CME with the relevant information.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lectures AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Workshop AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine MOC*

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

*Please note MOC points will not be available for the workshop.

MSK Course Directors

Jennifer Liu, MD
Director, Cardiovascular Laboratories
Attending Physician
Memorial Sloan Kettering Cancer Center
Associate Professor of Clinical Medicine
Weill Cornell Medical College

Richard M. Steingart, MD
Chief, Cardiology Service 
Attending Physician,
Memorial Sloan Kettering Cancer Center
Professor of Medicine,
Weill Cornell Medical College

Valentin Fuster, MD, PhD
Physician-in-Chief
Director, Mount Sinai Heart
Director, Zena and Michael A. Wiener Cardiovascular Institute Director, Marie-Josée and Henry R. Kravis Center for Cardiovascular Health
Mount Sinai Medical Hospital
Richard Gorlin, MD/Heart Research Foundation Professor
Icahn School of Medicine at Mount Sinai

MSK Faculty

Michael Baum, MD
Cardiology Service

Oren Cahlon, MD 
Radiation Oncology  

Angel Chan, MD, PhD 
Cardiology Service

Carol Chen, MD 
Cardiology Service

Chau Dang, MD 
Breast Oncology Service

Dipti Gupta, MD, MPH 
Cardiology Service

Michelle Johnson, MD, MPH
Cardiology Service

Katherine Lee-Chuy, MD 
Cardiology Service

Michael Postow, MD 
Melanoma Service

Wendy Schaffer, MD PhD 
Cardiology Service

Gerald Soff, MD 
Benign Hematology Service

Ji Can Yang, DO 
Cardiology Service

Anthony Yu, MD 
Cardiology Service

Invited Faculty

Usman Baber MD 
Mt. Sinai Hospital

Ana Barac, MD, PhD  
MedStar Washington Hospital Center

Ann Blaes, MD 
University of Minnesota 

Jim Cheung, MD 
Weill Cornell Medical Center

Susan Dent, MD 
University of Ottawa

Michael Fradley, MD
University of South Florida

Joerg Herrmann, MD 
Mayo Clinic

Daniel Lenihan, MD 
Washington University

Tomas Neilan, MD, MPH
Massachusetts General Hospital

Anju Nohria, MD
Brigham and Women’s Hospital

Kevin Oeffinger, MD 
Duke University

Dinesh Thavendiranathan, MD 
Toronto General Hospital
University Health Network

Jonathan Weinsaft, MD 
Weill Cornell Medical Center

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing educational grants, financial support, or in-kind product donation for this live activity:

• Bristol-Myers Squibb
• GE Healthcare
• Lantheus Medical Imaging
• Philips Healthcare
• TOMTEC CORPORATION